David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
2176
Nebius Group N.V.
NBIS
$58.2B
| $3.09M | ﹤0.01% |
189,102
| – | – |
|
|
EHAB
2177
DELISTED
Enhabit
EHAB
| $3.09M | ﹤0.01% |
298,099
-54,581
| -15% | -$516K |
|
2178
Kopin
KOPN
$879M
| $3.08M | ﹤0.01% |
1,515,718
-104,804
| -6% | -$150K |
|
|
LKFT
2179
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $3.07M | ﹤0.01% |
75,640
+18,295
| +32% | +$673K |
|
2180
Stevanato
STVN
$6.11B
| $3.07M | ﹤0.01% |
112,452
-6,982
| -6% | -$201K |
|
2181
Takeda Pharmaceutical
TAK
$58.2B
| $3.07M | ﹤0.01% |
214,957
-52,938
| -20% | -$751K |
|
2182
Tactile Systems Technology
TCMD
$533M
| $3.05M | ﹤0.01% |
213,455
-165,017
| -44% | -$2.07M |
|
|
AYX
2183
CALL
DELISTED
Alteryx Inc
AYX
| $3.05M | ﹤0.01% |
64,700
+10,000
| +18% | +$388K |
|
2184
PUT
Conagra Brands
CAG
$7.77B
| $3.04M | ﹤0.01% |
106,200
+4,700
| +5% | +$132K |
|
2185
Compass
COMP
$8.74B
| $3.04M | ﹤0.01% |
808,358
+8,151
| +1% | +$20.1K |
|
2186
Designer Brands
DBI
$290M
| $3.04M | ﹤0.01% |
343,332
-21,376
| -6% | -$225K |
|
2187
PUT
Gen Digital
GEN
$17.7B
| $3.04M | ﹤0.01% |
+133,100
| New | +$2.64M |
|
2188
Primoris Services
PRIM
$4.21B
| $3.04M | ﹤0.01% |
91,420
+8,146
| +10% | +$254K |
|
2189
CALL
Canadian Solar
CSIQ
$942M
| $3.03M | ﹤0.01% |
115,700
+46,500
| +67% | +$1.03M |
|
2190
CALL
Axcelis
ACLS
$3.72B
| $3.02M | ﹤0.01% |
23,300
-35,700
| -61% | -$4.92M |
|
2191
CALL
RingCentral
RNG
$5.52B
| $3.02M | ﹤0.01% |
89,000
+1,500
| +2% | +$44.8K |
|
|
NOA
2192
North American Construction
NOA
$358M
| $3.02M | ﹤0.01% |
144,800
-24,500
| -14% | -$505K |
|
|
PR
2193
CALL
Permian Resources
PR
$19.1B
| $3.02M | ﹤0.01% |
222,096
+200,596
| +933% | +$2.75M |
|
2194
Honeywell
HON
$69.9B
| $3.01M | ﹤0.01% |
15,225
-384,084
| -96% | -$69.2M |
|
2195
PUT
H&R Block
HRB
$6.49B
| $3.01M | ﹤0.01% |
62,200
| – | – |
|
2196
CALL
AMN Healthcare
AMN
$1.33B
| $3M | ﹤0.01% |
+40,000
| New | +$2.86M |
|
2197
CALL
Stryker
SYK
$126B
| $2.99M | ﹤0.01% |
10,000
-9,800
| -49% | -$2.75M |
|
2198
Royal Bank of Canada
RY
$288B
| $2.99M | ﹤0.01% |
29,600
-398,754
| -93% | -$35.1M |
|
2199
RXO
RXO
$3.66B
| $2.99M | ﹤0.01% |
128,606
+110,906
| +627% | +$2.23M |
|
2200
Build-A-Bear
BBW
$490M
| $2.98M | ﹤0.01% |
129,834
+18,688
| +17% | +$473K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.